Ohio § 3701.139

§ 3701.139.

(A) Subject to division (B) of this section, the director of health shall convene meetings

with staff of the department of health, department of medicaid, department of administrative

services, and commission on minority health to do all of the following: (1) Assess the prevalence of all types of diabetes in this state, including disparities

in that prevalence among various demographic populations and local jurisdictions; (2) Establish and reevaluate goals for each of the agencies to reduce that prevalence; (3) Identify how to measure the progress achieved toward attaining the goals established

under division (A)(2) of this section; (4) Establish and monitor the implementation of plans for each agency to reduce the prevalence

of all types of diabetes, improve diabetes care, and control complications associated

with diabetes among the populations of concern to each agency; (5) Consider any other matter associated with reducing the prevalence of all types of

diabetes in this state that the director considers appropriate; (6) Collect the information needed to prepare the reports required by division (C) of

this section. (B) The director shall convene the meetings required by division (A) of this section

at the director's discretion, but not less than twice each calendar year. (C) Not later than the thirty-first day of January of every third year beginning in 2021,

the director shall submit a report to the general assembly in accordance with section 101.68 of the Revised Code that addresses or contains all of the following for the three-year period preceding

the report's submission: (1) The results of the assessment required by division (A)(1) of this section; (2) The progress each agency has made toward achieving the goals established under division

(A)(2) of this section and implementing the plans required by division (A)(4) of this

section; (3) An assessment of the health and financial impacts that all types of diabetes have

had on the state and local jurisdictions, and, subject to division (D) of this section,

each agency specified in division (A) of this section; (4) A description of the efforts the agencies specified in division (A) of this section

have taken to coordinate programs intended to prevent, treat, and manage all types

of diabetes and associated complications; (5) Recommendations for legislative policies to reduce the impact that diabetes, pre-diabetes,

and complications from diabetes have on the citizens of this state, including specific

action steps that could be taken, the expected outcomes of the action steps, and benchmarks

for measuring progress toward achieving the outcomes; (6) A budget proposal that identifies the needs and resources required to implement the

recommendations described in division (C)(5) of this section, as well as estimates

of the costs to implement the recommendations; (7) Any other information concerning diabetes prevention, treatment, or management in

this state that the director considers appropriate. (D) An agency-specific assessment required by division (C) of this section shall include

all of the following: (1) A list and description of each diabetes prevention or control program the agency

administers, the number of individuals with each type of diabetes and their dependents

who are impacted by each program, the expenses associated with administering each

program, and the funds appropriated for each program, along with each funding source; (2) A comparison of the expenses described in division (D)(1) of this section with the

expenses the agency incurs in administering programs to reduce the prevalence of other

chronic diseases and conditions; (3) An evaluation of the benefits that have resulted from each program listed pursuant

to division (D)(1) of this section. (E) Nothing in this section requires the agencies specified in division (A) of this section

to establish programs for diabetes prevention, treatment, and management that had

not been initiated or funded prior to April 6, 2017.